Back


20/11/2018
Stilla Technologies completes €16 Million ($18 Million) Series A
Stilla Technologies, the European provider of pioneering digital PCR solutions for high precision genetic analysis, announced today the successful completion of a Series A financing round of 16 million euros ($18 Million) led by Illumina Ventures, with participation from from Kurma Partners, LBO France, BNP Paribas Développement, Paris Saclay Seeds & Idinvest Partners. [...]

Download the pdf file





X

X